Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Eukaryotic Gene Expression
Импакт фактор: 2.156 5-летний Импакт фактор: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Печать: 1045-4403
ISSN Онлайн: 2162-6502

Выпуски:
Том 30, 2020 Том 29, 2019 Том 28, 2018 Том 27, 2017 Том 26, 2016 Том 25, 2015 Том 24, 2014 Том 23, 2013 Том 22, 2012 Том 21, 2011 Том 20, 2010 Том 19, 2009 Том 18, 2008 Том 17, 2007 Том 16, 2006 Том 15, 2005 Том 14, 2004 Том 13, 2003 Том 12, 2002 Том 11, 2001 Том 10, 2000 Том 9, 1999 Том 8, 1998 Том 7, 1997 Том 6, 1996 Том 5, 1995 Том 4, 1994

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.v13.i24.100
8 pages

Expression of Vascular Endothelial Growth Factor in the Dental Follicle

Gary E. Wise
Professor and Head Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803
S. Yao
Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803

Краткое описание

Tooth eruption requires the presence of the dental follicle to recruit mononuclear cells, which fuse to form osteoclasts that resorb the alveolar bone such that the tooth can erupt. In the rat first mandibular molar, there is a major burst of osteoclastogenesis at day 3 postnatally and a lesser burst at day 10. Eruption molecules, such as CSF-1, are maximally expressed at day 3 in the dental follicle to promote this maximal osteoclast formation, but by the time of the secondary burst of osteoclastogenesis their expression is dramatically reduced. Because vascular endothelial growth factor (VEGF) can substitute for CSF-1 to promote osteoclastogenesis, we examined its gene expression in vivo in the dental follicle and found that it and its two major isoforms (VEGF 120 and 164) were all maximally expressed at days 9–11, the time of the secondary burst. Treatment of the cells with phorbolmyristate acetate (PMA), a protein kinase C (PKC) activator, enhanced expression of the 2 major VEGF isoforms in the cultured dental follicle cells, whereas adding a specific PKC inhibitor prevented this. Treatment with PMA also increased the protein level of VEGF. Thus, VEGF may be involved in promoting the secondary burst of osteoclastogenesis, and activation of PKC may upregulate its expression.


Articles with similar content:

Signals for Activation of the GM-CSF Promoter and Enhancer in T Cells
Critical Reviews™ in Immunology, Vol.17, 1997, issue 3-4
M. Frances Shannon, M. A. Vadas, P. N. Cockerill, L. S Coles
The Regulation and Regulatory Role of Collagenase in Bone
Critical Reviews™ in Eukaryotic Gene Expression, Vol.6, 1996, issue 1
Prince T. Chan, Terry H. Omura, Nicola C. Partridge, A. Terrece Pearman, Wan-Yin Chou, Sharon R. Bloch, Hobart W. Walling
Curcumin, a Potential Inhibitor of MMP-2 in Human Laryngeal Squamous Carcinoma Cells HEp2
Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 4
Amitava Chatterjee, Jayati Chakrabarti, Aparna Mitra, B. R. Das, Aniruddha Banerji
Molecular Mechanisms of Tumor-Bone Interactions in Osteolytic Metastases
Critical Reviews™ in Eukaryotic Gene Expression, Vol.10, 2000, issue 2
Theresa A. Guise, John M. Chirgwin
A Nitric Oxide Producing Pin-to-Hole Spark Discharge Plasma Enhances Endothelial Cell Proliferation and Migration
Plasma Medicine, Vol.1, 2011, issue 3-4
Krishna Priya Arjunan, Alisa Morss Clyne